AVEO Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on AVEO Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date AVEO Pharmaceuticals Inc Strategy Report
- Understand AVEO Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
AVEO Pharmaceuticals Catalyst Calendar
Proactively evaluate AVEO Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of AVEO Pharmaceuticals Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 31 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 10 Oct 2020 | Phase I/II Trial Completion | AVEO Pharmaceuticals Inc; Biodesix Inc; Dana-Farber Cancer Institute Inc; Dana-Farber/Harvard Cancer Center | BDSX | ficlatuzumab | Oncology | Metastatic Adenocarcinoma of The Pancreas; Metastatic Pancreatic Cancer; Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma | Clinical Trial Registry |
| 31 Mar 2020 | NDA/BLA Filing (US) | AVEO Pharmaceuticals Inc | - | tivozanib hydrochloride | Oncology | Renal Cell Carcinoma | Company Press Release |
| 31 Dec 2019 | Phase III Trial Results | AVEO Pharmaceuticals Inc; Parexel International Corp | - | tivozanib hydrochloride | Oncology | Metastatic Renal Cell Carcinoma; Renal Cell Carcinoma | Company Press Release |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer